Astrana Health, Inc. Quarterly Costs and Expenses in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Astrana Health, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
  • Astrana Health, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $450M, a 45.7% increase year-over-year.
  • Astrana Health, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $1.64B, a 33.5% increase year-over-year.
  • Astrana Health, Inc. annual Costs and Expenses for 2023 was $1.3B, a 25.2% increase from 2022.
  • Astrana Health, Inc. annual Costs and Expenses for 2022 was $1.04B, a 53.9% increase from 2021.
  • Astrana Health, Inc. annual Costs and Expenses for 2021 was $676M, a 11.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.64B $450M +$141M +45.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.5B $456M +$135M +42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.36B $374M +$59.3M +18.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.3B $357M +$75.3M +26.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.23B $309M +$42.2M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.18B $321M +$66.9M +26.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.12B $315M +$77.8M +32.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.04B $282M +$88.8M +46% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-08-09
Q3 2022 $951M $267M +$93M +53.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $858M $254M +$99.7M +64.4% Apr 1, 2022 Jun 30, 2022 10-K/A 2023-08-09
Q1 2022 $759M $237M +$82.8M +53.7% Jan 1, 2022 Mar 31, 2022 10-Q/A 2023-08-09
Q4 2021 $676M $193M +$41.9M +27.8% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-08-09
Q3 2021 $634M $174M +$31.2M +21.8% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-08-09
Q2 2021 $603M $155M +$2.39M +1.57% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-08-09
Q1 2021 $600M $154M -$6.46M -4.02% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-08-09
Q4 2020 $607M $151M -$16.9M -10.1% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-08-09
Q3 2020 $624M $143M -$3.23M -2.21% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $627M $152M +$36.9M +32% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $590M $161M +$61.7M +62.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $528M $168M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $146M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $115M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $99.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.